Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
5 hedge funds and large institutions have $1.29M invested in Onconova Therapeutics, Inc. Warrants in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
677% more capital inflows, than outflows
Capital inflows: $239K | Capital outflows: $30.8K
67% more funds holding
Funds holding: 3 → 5 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$155K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$84.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$30.8K |
ONTXW Hedge Fund Activity: Q4 2016 in Review
5 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q4 2016, worth a combined $1.29M — down 27% from $1.76M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ONTXW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $155K. The largest seller was Sabby Management, cutting an estimated $30.8K.
- 5 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q4 2016, up from 3 in Q3 2016.
- Funds reported $1.29M of Onconova Therapeutics, Inc. Warrants stock for Q4 2016, down 27% quarter-over-quarter.
- 2 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q4 2016 and 0 closed out, a net change of +2 holders.
- The largest Onconova Therapeutics, Inc. Warrants buyer in Q4 2016 was Susquehanna International Group, an estimated $155K added.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q4 2016 was Sabby Management, an estimated $30.8K sold.
Based on aggregated 13F filings for Q4 2016.